Skip to content
Cash Flow Statement · TASI 8040

Mutakamela Insurance Co.
Cash and cash equivalents at period end · Insurance operations history.

Cash and cash equivalents at the end of each reporting period. Figures apply to insurance operations. Explore 18 reported observations from 2018 to 2022, with every value linked to its official evidence.

Coverage2018–202218 source-linked periods
Annual history3annual reporting periods
Interim history15quarterly or year-to-date periods
StatementCash Flow Statementas reported by the issuer
Annual series

Cash and cash equivalents at period end · Insurance operations

The series uses the same reporting duration and currency. The filing values appear below.

2020IFRS 4Cash and cash equivalents at period end · Insurance operations187.64M SAR
Cash and cash equivalents at period end · Insurance operations050M100M150M200M201820192020
Hover or tap to exploreSAR
First-quarter series

Cash and cash equivalents at period end · Insurance operations

The series uses the same reporting duration and currency. The filing values appear below.

2022IFRS 4Cash and cash equivalents at period end · Insurance operations39.05M SAR
Cash and cash equivalents at period end · Insurance operations025M50M75M100M20182019202020212022
Hover or tap to exploreSAR
Half-year series

Cash and cash equivalents at period end · Insurance operations

The series uses the same reporting duration and currency. The filing values appear below.

2022IFRS 4Cash and cash equivalents at period end · Insurance operations40.52M SAR
Cash and cash equivalents at period end · Insurance operations025M50M75M100M20182019202020212022
Hover or tap to exploreSAR
Nine-month series

Cash and cash equivalents at period end · Insurance operations

The series uses the same reporting duration and currency. The filing values appear below.

2022IFRS 4Cash and cash equivalents at period end · Insurance operations164.9M SAR
Cash and cash equivalents at period end · Insurance operations050M100M150M200M250M20182019202020212022
Hover or tap to exploreSAR
Official evidence ledger

Every value, period and source.

Normalized values support comparison. The reported value and unit preserve the original filing presentation.

PeriodReported valueComparable valueReported lineEvidence
9M / Q3 20222022-09-30164,895,9312022-01-01 to 2022-09-30164.9M SARCash and cash equivalents at end of periodNote 4Official p. 8 ↗Open statement →
H1 / Q2 20222022-06-3040,517,5872022-01-01 to 2022-06-3040.52M SARCash and cash equivalents at end of periodNote 4Official source ↗Open statement →
Q1 20222022-03-3139,046,4042022-01-01 to 2022-03-3139.05M SARCash and cash equivalents at end of periodNote 4Official source ↗Open statement →
9M / Q3 20212021-09-3038,676,9182021-01-01 to 2021-09-3038.68M SARCash and cash equivalents at end of periodNote 4Official source ↗Open statement →
H1 / Q2 20212021-06-3041,419,7212021-01-01 to 2021-06-3041.42M SARCash and cash equivalents at end of periodNote 4Official source ↗Open statement →
Q1 20212021-03-3152,599,6402021-01-01 to 2021-03-3152.6M SARCash and cash equivalents at end of periodNote 4Official source ↗Open statement →
FY 20202020-12-31187,639,5582020-01-01 to 2020-12-31187.64M SARCash and cash equivalents at end of periodOfficial source ↗Open statement →
9M / Q3 20202020-09-30201,711,2342020-01-01 to 2020-09-30201.71M SARCash and cash equivalents at end of periodOfficial source ↗Open statement →
H1 / Q2 20202020-06-3031,535,1522020-01-01 to 2020-06-3031.54M SARCash and cash equivalents at end of periodOfficial source ↗Open statement →
Q1 20202020-03-3175,319,8282020-01-01 to 2020-03-3175.32M SARCash and cash equivalents at end of periodNote 4Official source ↗Open statement →
FY 20192019-12-3187,046,4262019-01-01 to 2019-12-3187.05M SARCash and cash equivalents at end of periodNote 4Official source ↗Open statement →
9M / Q3 20192019-09-3098,802,6932019-01-01 to 2019-09-3098.8M SARCash and cash equivalents at end of periodNote 4Official source ↗Open statement →
H1 / Q2 20192019-06-3094,139,9432019-01-01 to 2019-06-3094.14M SARCash and cash equivalents at end of periodNote 4Official source ↗Open statement →
Q1 20192019-03-3195,928,5042019-01-01 to 2019-03-3195.93M SARCash and cash equivalents at end of periodNote 4Official source ↗Open statement →
FY 20182018-12-3147,722,5032018-01-01 to 2018-12-3147.72M SARCash and cash equivalents at end of periodNote 4Official p. 44 ↗Open statement →
9M / Q3 20182018-09-3057,716,4142018-01-01 to 2018-09-3057.72M SARCash and cash equivalents at end of periodOfficial source ↗Open statement →
H1 / Q2 20182018-06-3039,422,5402018-01-01 to 2018-06-3039.42M SARCash and cash equivalents at end of periodOfficial source ↗Open statement →
Q1 20182018-03-3137,606,2302018-01-01 to 2018-03-3137.61M SARCash and cash equivalents at end of periodNote 4Official source ↗Open statement →
How to read this series

Reported first. Comparable second.

We show the original label and figure alongside its normalized value. Annual, first-quarter, half-year and nine-month series are separate. Per-share figures keep the issuer’s reported share basis.

سجل مالي موثق بالمصدر

متكاملة — Cash and cash equivalents at period end · Insurance operations

تُعرض القيم كما وردت في القوائم المالية الرسمية، مع فصل الفترات السنوية والمرحلية وربط كل قيمة بصفحة المصدر الرسمي. تُعرض ربحية السهم وفق أساس الأسهم الوارد في كل تقرير.